Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | NT5E | P21589 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14718327 | 0.89 | CA2 (0.36) | CA2CA1TSHRUSP2 | |
| SCHEMBL27418084 | 0.85 | CA1 (0.33) | CA2CA1TSHRTDP1 | |
| Ammonia Solution, Strong SCHEMBL18690256 | 0.81 | CA2 (0.39) | CA2CA1TSHRUSP2CA5A | |
| SCHEMBL3967860 | 0.81 | CA2 (0.35) | CA2CA1TSHRUSP2TDP1 | |
| SCHEMBL6945178 | 0.81 | CA2 (0.35) | CA2CA1TSHRUSP2 | |
| Sulfuric Acid SCHEMBL2127329 | 0.81 | CA5A (0.46) | CA2CA1TSHRNT5ECA4 | |
| Hydroxyamine SCHEMBL27900806 | 0.81 | — | — | |
| Hydrazine SCHEMBL679587 | 0.81 | — | — | |
| Methylamine SCHEMBL143865 | 0.81 | — | — | |
| SCHEMBL5991 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105555940-A | Particles | PROCTER & GAMBLE | 2016-05-04 | — | — | CN | claimed |
| US-20250163346-A1 | TREATMENT COMPOSITIONS | PROCTER & GAMBLE (US) | 2025-05-22 | — | — | US | disclosed |
| EP-3307129-B1 | DEVICE AND METHODS FOR APPLYING COMPOSITIONS TO SURFACES | PROCTER & GAMBLE (US) | 2025-02-26 | — | — | EP | disclosed |
| US-12215299-B2 | Treatment compositions | THE PROCTER & GAMBLE COMPANY (US) | 2025-02-04 | — | — | US | disclosed |
| US-12203219-B2 | Fibrous structures comprising a surfactant | THE PROCTER & GAMBLE COMPANY (US) | 2025-01-21 | — | — | US | disclosed |
| US-20230242842-A1 | TREATMENT COMPOSITIONS | PROCTER & GAMBLE (US) | 2023-08-03 | — | — | US | disclosed |
| US-11643618-B2 | Treatment compositions | THE PROCTER & GAMBLE COMPANY (US) | 2023-05-09 | — | — | US | disclosed |
| US-20220380982-A1 | FIBROUS STRUCTURES COMPRISING A SURFACTANT | PROCTER & GAMBLE (US) | 2022-12-01 | — | — | US | disclosed |
| US-11401662-B2 | Fibrous structures comprising a surfactant | THE PROCTER & GAMBLE COMPANY (US) | 2022-08-02 | — | — | US | disclosed |
| US-11306275-B2 | Treatment compositions | THE PROCTER & GAMBLE COMPANY (US) | 2022-04-19 | — | — | US | disclosed |
| EP-2459606-A1 | HYBRID COPOLYMER COMPOSITIONS | Akzo Nobel N.V. (NL) | 2012-06-06 | — | — | EP | disclosed |
| WO-2011014783-A1 | HYBRID COPOLYMER COMPOSITIONS | AKZO NOBEL N.V. (NL) | 2011-02-03 | — | — | WO | disclosed |
| EP-2122043-A1 | FABRIC COLOR RESTORATION COMPOSITION, ARTICLE, AND METHOD | The Procter & Gamble (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008084460-A1 | FABRIC COLOR RESTORATION COMPOSITION, ARTICLE, AND METHOD | THE PROCTER & GAMBLE COMPANY (US) | 2008-07-17 | — | — | WO | disclosed |
| EP-1255806-A1 | STABLE, AQUEOUS COMPOSITIONS FOR TREATING SURFACES, ESPECIALLY FABRICS | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-13 | — | — | EP | disclosed |
| WO-2001060961-A1 | STABLE, AQUEOUS COMPOSITIONS FOR TREATING SURFACES, ESPECIALLY FABRICS | THE PROCTER & GAMBLE COMPANY (US) | 2001-08-23 | — | — | WO | disclosed |
| EP-0989895-A1 | PROCESS FOR IMPROVING THE ODOR OF COMMERCIAL SOLVENT USED IN FABRIC SOFTENING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-04-05 | — | — | EP | disclosed |
| EP-0985013-A1 | SOFTENER ACTIVE DERIVED FROM ACYLATED TRIETHANOLAMINE | THE PROCTER & GAMBLE COMPANY (US) | 2000-03-15 | — | — | EP | disclosed |
| WO-1998057721-A1 | PROCESS FOR IMPROVING THE ODOR OF COMMERCIAL SOLVENT USED IN FABRIC SOFTENING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-23 | — | — | WO | disclosed |
| WO-1998047991-A1 | SOFTENER ACTIVE DERIVED FROM ACYLATED TRIETHANOLAMINE | THE PROCTER & GAMBLE COMPANY (US) | 1998-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11401662-B2 | Fibrous structures comprising a surfactant | SMURF1, CUTA, SMURF2 | CA2 4710/4885CA1 3270/4885TSHR 4514/4885 |
| US-12203219-B2 | Fibrous structures comprising a surfactant | SMURF1, CUTA, SMURF2 | CA2 4710/4885CA1 3270/4885TSHR 4514/4885 |
| US-20220380982-A1 | FIBROUS STRUCTURES COMPRISING A SURFACTANT | SMURF1, CUTA, SMURF2 | CA2 4710/4885CA1 3270/4885TSHR 4514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.